TSC
Showing 26 - 50 of 236
Burn Out (Psychology) Trial (TSC program (Three Self-Commitment program))
Not yet recruiting
- Burn Out (Psychology)
- TSC program (Three Self-Commitment program)
- (no location specified)
Jul 21, 2021
Glioblastoma Trial in United States (Trans Sodium Crocetinate plus SOC, Standard of Care (SOC))
Terminated
- Glioblastoma
- Trans Sodium Crocetinate plus SOC
- Standard of Care (SOC)
-
Irvine, California
- +12 more
Jul 1, 2021
Diagnosis and Treatment Management of Rare Neurological Disease
Withdrawn
- Xlsma
- +3 more
-
Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2021
Angiofibromas, Tuberous Sclerosis Trial in Australia, United States (Placebo, Rapamycin)
Completed
- Angiofibromas
- Tuberous Sclerosis
- Placebo
- Rapamycin
-
Birmingham, Alabama
- +9 more
Sep 30, 2020
Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )
Completed
- Facial Angiofibroma
- Tuberous Sclerosis
- rapamycin
- placebo
-
Phoenix, Arizona
- +16 more
Jul 26, 2022
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Philadelphia (Simvastatin, Sirolimus Oral Product, Everolimus Oral
Completed
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
- Simvastatin
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Aug 12, 2020
Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)
Active, not recruiting
- Tuberous Sclerosis Complex
- Vigabatrin
- Placebo
-
Birmingham, Alabama
- +12 more
May 4, 2022
Studies in Patients With Tuberous Sclerosis Complex
Recruiting
- Tuberous Sclerosis Complex
-
Phoenix, ArizonaTranslational Genomics Research Institute (TGen)
Oct 18, 2022
Interstitial Lung Disease Trial in Phoenix (Trans Sodium Crocetinate, Placebo)
Terminated
- Interstitial Lung Disease
- Trans Sodium Crocetinate
- Placebo
-
Phoenix, ArizonaPulmonary Associates, P.A.
Aug 8, 2022
Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to
Recruiting
- Tuberous Sclerosis Complex
- Basimglurant with crossover to Placebo
- Placebo with crossover to Basimglurant
-
Phoenix, Arizona
- +47 more
Jan 3, 2023
Growth and Development Trial in Belgium, Russian Federation, United States (Everolimus, Envirolimus drug class as prescribed by
Active, not recruiting
- Growth and Development
- Everolimus
- Envirolimus drug class as prescribed by Physician
-
Los Angeles, California
- +5 more
Dec 5, 2022
Healthy Volunteers With Induced Hypoxia Trial in Durham (Trans Sodium Crocetinate)
Completed
- Healthy Volunteers With Induced Hypoxia
- Trans Sodium Crocetinate
-
Durham, North CarolinaDuke University Medical Center
Apr 12, 2022
Tuberous Sclerosis Complex, Aspirin, Epilepsy Trial in Beijing (Aspirin, AED, Placebo)
Unknown status
- Tuberous Sclerosis Complex
- +4 more
- Aspirin
- +2 more
-
Beijing, Beijing, ChinaDepartment of Neurology, Peking Union Medical College Hospital
Jun 5, 2020
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution
Not yet recruiting
- Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
- Cannabidiol Oral Solution [Epidiolex]
-
Los Angeles, California
- +6 more
May 9, 2023
Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)
Recruiting
- Lymphangioleiomyomatosis
- Tuberous Sclerosis Complex
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +32 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +124 more
Aug 24, 2022
Unplanned Hospital Readmissions, Patients at High Risk of Unplanned Readmission Trial in Winston-Salem (Epic 30-day unplanned
Not yet recruiting
- Unplanned Hospital Readmissions
- Patients at High Risk of Unplanned Readmission
- Epic 30-day unplanned readmission risk score
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Dec 21, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +17 more
- Biopsy
- +3 more
-
Augusta, Georgia
- +4 more
Jan 25, 2023
Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))
Recruiting
- Tuberous Sclerosis Complex
- Acceptance and Commitment Therapy (ACT)
-
Bristol, United KingdomUniversity Hospitals Bristol and Weston NHS Trust
May 10, 2023
Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)
Recruiting
- Angiofibroma of Face
- Tuberous Sclerosis
- Sirolimus 0.2%
- +2 more
-
Phoenix, Arizona
- +7 more
Feb 2, 2022
Data Set Re-use With Statistical Methodologies Tailored for
Recruiting
- Tuberous Sclerosis
- Epilepsy
-
Paris, FranceRima Nabbout
Jan 5, 2022
Neurocutaneous Syndromes in Upper Egypt Children
Not yet recruiting
- Neurocutaneous Syndromes
- (no location specified)
Sep 10, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in New York (Sodium (Na) Magnetic Resonance Imaging (MRI), Dynamic Contrast-
Terminated
- Breast Cancer
- Triple Negative Breast Cancer
- Sodium (Na) Magnetic Resonance Imaging (MRI)
- Dynamic Contrast- Enhanced (DCE) MRI
-
New York, New YorkNYU Langone Health
Aug 1, 2022
DLBCL - Diffuse Large B Cell Lymphoma Trial in Toronto (Cyclophosphamide, TLI)
Recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- Cyclophosphamide
- TLI
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jul 19, 2023